nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accuracy of magnetic resonance in suspicious breast lesions: a systematic quantitative review and meta-analysis
|
Medeiros, Lidia Rosi |
|
2011 |
126 |
2 |
p. 273-285 |
artikel |
2 |
A gene expression signature identifies two prognostic subgroups of basal breast cancer
|
Sabatier, Renaud |
|
2010 |
126 |
2 |
p. 407-420 |
artikel |
3 |
A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese population
|
Jiang, Lan |
|
2010 |
126 |
2 |
p. 487-495 |
artikel |
4 |
A randomized, placebo-controlled trial (NCIC CTG MAP.2) examining the effects of exemestane on mammographic breast density, bone density, markers of bone metabolism and serum lipid levels in postmenopausal women
|
Cigler, T. |
|
2011 |
126 |
2 |
p. 453-461 |
artikel |
5 |
Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer
|
Dent, Susan F. |
|
2011 |
126 |
2 |
p. 295-310 |
artikel |
6 |
CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer
|
Kmieciak, Maciej |
|
2010 |
126 |
2 |
p. 385-394 |
artikel |
7 |
Dietary glycemic index, glycemic load, and risk of breast cancer: meta-analysis of prospective cohort studies
|
Dong, Jia-Yi |
|
2011 |
126 |
2 |
p. 287-294 |
artikel |
8 |
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
|
Hershman, Dawn L. |
|
2010 |
126 |
2 |
p. 529-537 |
artikel |
9 |
Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial
|
Bernsdorf, Mogens |
|
2011 |
126 |
2 |
p. 463-470 |
artikel |
10 |
Effects on survival of menstrual cycle phase of adjuvant surgical oophorectomy in premenopausal women with breast cancer
|
Love, Richard R. |
|
2011 |
126 |
2 |
p. 479-485 |
artikel |
11 |
Fragment c gamma receptor gene polymorphisms and breast cancer risk in case–control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians
|
Iwasaki, Motoki |
|
2010 |
126 |
2 |
p. 497-505 |
artikel |
12 |
Functional implication of TRAIL −716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor
|
Pal, Ranjana |
|
2010 |
126 |
2 |
p. 333-343 |
artikel |
13 |
Human papillomavirus infection and sporadic breast carcinoma risk: a meta-analysis
|
Li, Ni |
|
2010 |
126 |
2 |
p. 515-520 |
artikel |
14 |
Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas
|
Wargon, Victoria |
|
2010 |
126 |
2 |
p. 319-332 |
artikel |
15 |
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen
|
Khoshnoud, Mahmoud R. |
|
2010 |
126 |
2 |
p. 421-430 |
artikel |
16 |
Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors
|
Amemiya, Y. |
|
2010 |
126 |
2 |
p. 373-384 |
artikel |
17 |
Is PCR testing of sentinel lymph nodes ready for clinical application in breast cancer?
|
Anderson, Benjamin O. |
|
2008 |
126 |
2 |
p. 551-553 |
artikel |
18 |
Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer
|
Torrisi, Rosalba |
|
2011 |
126 |
2 |
p. 431-441 |
artikel |
19 |
MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study
|
Beeghly-Fadiel, Alicia |
|
2010 |
126 |
2 |
p. 507-513 |
artikel |
20 |
Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer
|
Masuda, Norikazu |
|
2011 |
126 |
2 |
p. 443-451 |
artikel |
21 |
Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy
|
Silvestri, Valentina |
|
2010 |
126 |
2 |
p. 539-543 |
artikel |
22 |
Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers
|
Yan, Max |
|
2010 |
126 |
2 |
p. 395-405 |
artikel |
23 |
Overexpression of HER2 signaling to WAVE2–Arp2/3 complex activates MMP-independent migration in breast cancer
|
Yokotsuka, Mayumi |
|
2010 |
126 |
2 |
p. 311-318 |
artikel |
24 |
PALB2 mutations in German and Russian patients with bilateral breast cancer
|
Bogdanova, Natalia |
|
2010 |
126 |
2 |
p. 545-550 |
artikel |
25 |
Preclinical evaluation of nuclear morphometry and tissue topology for breast carcinoma detection and margin assessment
|
Nyirenda, Ndeke |
|
2010 |
126 |
2 |
p. 345-354 |
artikel |
26 |
RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies
|
Yu, Ke-Da |
|
2010 |
126 |
2 |
p. 365-371 |
artikel |
27 |
The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
|
Vazquez-Martin, Alejandro |
|
2010 |
126 |
2 |
p. 355-364 |
artikel |
28 |
The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers
|
Kaufman, Bella |
|
2010 |
126 |
2 |
p. 521-527 |
artikel |
29 |
The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients
|
Bae, Soo Youn |
|
2011 |
126 |
2 |
p. 471-478 |
artikel |